In AAV, seropositivity for MPO or PR3-ANCA, rather than serial measures of titer, appear to have greater clinical value in predicting disease course [23,24,25,27]. The gene discussed is MPO; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.